-
1
-
-
0032601052
-
Descriptive epidemiology of primary brain and CNS tumors: Results from the central brain tumor registry of the United States, 1990-1994
-
Surawicz TS, et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol. 1999;1(1):14-25.
-
(1999)
Neuro. Oncol.
, vol.1
, Issue.1
, pp. 14-25
-
-
Surawicz, T.S.1
-
2
-
-
0019142613
-
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
-
Walker MD, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980;303(23):1323-9.
-
(1980)
N. Engl. J. Med.
, vol.303
, Issue.23
, pp. 1323-1329
-
-
Walker, M.D.1
-
3
-
-
0027516695
-
Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
-
Fine HA, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993;71(8):2585-97.
-
(1993)
Cancer
, vol.71
, Issue.8
, pp. 2585-2597
-
-
Fine, H.A.1
-
4
-
-
0028917333
-
Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas the polymer-brain tumor treatment group
-
Brem H, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas The Polymer-brain Tumor Treatment Group. Lancet. 1995;345(8956):1008-12.
-
(1995)
Lancet
, vol.345
, Issue.8956
, pp. 1008-1012
-
-
Brem, H.1
-
5
-
-
0037384037
-
A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma
-
Westphal M, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol. 2003;5(2):79-88.
-
(2003)
Neuro. Oncol.
, vol.5
, Issue.2
, pp. 79-88
-
-
Westphal, M.1
-
6
-
-
33644787355
-
Gliadel wafer in initial surgery for malignant glioma: Long-term follow-up of a multicenter controlled trial
-
Westphal M, et al. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien). 2006;148(3):269-75.
-
(2006)
Acta Neurochir (Wien)
, vol.148
, Issue.3
, pp. 269-275
-
-
Westphal, M.1
-
7
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-96.
-
(2005)
N. Engl. J. Med.
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
-
8
-
-
36448938519
-
A phase 2 study of radiation with concomitant and then sequential temozolomide (TMZ) in patients with newly diagnosed supratentorial high-grade malignant glioma who have undergone surgery with carmustine (BCNU) wafer insertion [abstract]
-
LaRocca RV, et al. A phase 2 study of radiation with concomitant and then sequential temozolomide (TMZ) in patients with newly diagnosed supratentorial high-grade malignant glioma who have undergone surgery with carmustine (BCNU) wafer insertion [abstract]. Neuro Oncol. 2006;8(4):445.
-
(2006)
Neuro. Oncol.
, vol.8
, Issue.4
, pp. 445
-
-
LaRocca, R.V.1
-
9
-
-
49649104978
-
Mechanisms of chemoresistance to alkylating agents in malignant glioma
-
Sarkaria JN, et al. Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res. 2008;14(10):2900-8.
-
(2008)
Clin. Cancer Res.
, vol.14
, Issue.10
, pp. 2900-2908
-
-
Sarkaria, J.N.1
-
10
-
-
0033739125
-
Gliomas: WHO and sainte-anne hospital classifications
-
Daumas-Duport C, et al. [Gliomas: WHO and Sainte-Anne Hospital classifications]. Ann Pathol. 2000;20(5):413-28.
-
(2000)
Ann. Pathol.
, vol.20
, Issue.5
, pp. 413-428
-
-
Daumas-Duport, C.1
-
11
-
-
67649372741
-
Overall survival of primary glioblastoma (GBM) patients receiving carmustine (BCNU) wafers followed by radiation (RT) and concurrent temozolomide (TMZ) plus rotational multi-agent chemotherapy [abstract]
-
Rich JN, et al. Overall survival of primary glioblastoma (GBM) patients receiving carmustine (BCNU) wafers followed by radiation (RT) and concurrent temozolomide (TMZ) plus rotational multi-agent chemotherapy [abstract]. J Clin Oncol. 2007;25:2070.
-
(2007)
J. Clin. Oncol.
, vol.25
, pp. 2070
-
-
Rich, J.N.1
-
12
-
-
34247540921
-
Interstitial chemotherapy for malignant gliomas: The johns hopkins experience
-
Lawson HC, et al. Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol. 2007;83(1):61-70.
-
(2007)
J. Neurooncol
, vol.83
, Issue.1
, pp. 61-70
-
-
Lawson, H.C.1
-
13
-
-
0037443855
-
Risk factors for postcraniotomy surgical site infection after 1, 3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement
-
McGovern PC, et al. Risk factors for postcraniotomy surgical site infection after 1, 3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement. Clin Infect Dis. 2003;36(6):759-65.
-
(2003)
Clin. Infect. Dis.
, vol.36
, Issue.6
, pp. 759-765
-
-
McGovern, P.C.1
-
14
-
-
51649126636
-
Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: A 10-year institutional experience
-
Attenello FJ, et al. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol. 2008;15(10):2887-93.
-
(2008)
Ann. Surg. Oncol.
, vol.15
, Issue.10
, pp. 2887-2893
-
-
Attenello, F.J.1
-
15
-
-
0034032696
-
Tumor bed cyst formation after BCNU wafer implantation: Report of two cases
-
Engelhard HH, Tumor bed cyst formation after BCNU wafer implantation: report of two cases. Surg Neurol. 2000;53(3):220-4.
-
(2000)
Surg. Neurol.
, vol.53
, Issue.3
, pp. 220-224
-
-
Engelhard, H.H.1
-
16
-
-
1942473722
-
Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: Implications for patient management
-
Kleinberg LR, et al. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management. Cancer Invest. 2004;22(1):1-9.
-
(2004)
Cancer Invest.
, vol.22
, Issue.1
, pp. 1-9
-
-
Kleinberg, L.R.1
-
17
-
-
0036241641
-
Management of tumor bed cysts after chemo-therapeutic wafer implantation Report of four cases
-
McGirt MJ, et al. Management of tumor bed cysts after chemo-therapeutic wafer implantation Report of four cases. J Neurosurg. 2002;96(5):941-5.
-
(2002)
J. Neurosurg.
, vol.96
, Issue.5
, pp. 941-945
-
-
McGirt, M.J.1
-
18
-
-
57049163197
-
The role of proton magnetic resonance spectroscopy in the diagnosis and categorization of cerebral abscesses
-
Kapsalaki EZ, Gotsis ED, Fountas KN. The role of proton magnetic resonance spectroscopy in the diagnosis and categorization of cerebral abscesses. Neurosurg Focus. 2008;24(6):E7.
-
(2008)
Neurosurg. Focus
, vol.24
, Issue.6
-
-
Kapsalaki, E.Z.1
Gotsis, E.D.2
Fountas, K.N.3
-
19
-
-
0036732590
-
Brain abscess and necrotic brain tumor: Discrimination with proton MR spectroscopy and diffusion-weighted imaging
-
Lai PH, et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. AJNR Am J Neuroradiol. 2002;23(8):1369-77.
-
(2002)
AJNR Am. J. Neuroradiol
, vol.23
, Issue.8
, pp. 1369-1377
-
-
Lai, P.H.1
-
20
-
-
18044402671
-
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas
-
Gururangan S, et al. Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro Oncol. 2001;3(4):246-50.
-
(2001)
Neuro. Oncol.
, vol.3
, Issue.4
, pp. 246-250
-
-
Gururangan, S.1
-
21
-
-
0032984584
-
Morbidity and survival after 1, 3-bis (2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: A retrospective case-matched cohort series
-
Subach BR, et al. Morbidity and survival after 1, 3-bis (2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. Neurosurgery. 1999;45(1):17-22.
-
(1999)
Neurosurgery
, vol.45
, Issue.1
, pp. 17-22
-
-
Subach, B.R.1
-
22
-
-
14644431736
-
Cerebral edema associated with Gliadel wafers: Two case studies
-
Weber EL, Goebel EA. Cerebral edema associated with Gliadel wafers: two case studies. Neuro Oncol. 2005;7(1):84-9.
-
(2005)
Neuro. Oncol.
, vol.7
, Issue.1
, pp. 84-89
-
-
Weber, E.L.1
Goebel, E.A.2
-
23
-
-
33847626047
-
Fatal outcome related to carmustine implants in glioblastoma multiforme
-
Gallego JM, Barcia JA, Barcia-Marino C. Fatal outcome related to carmustine implants in glioblastoma multiforme. Acta Neurochir (Wien). 2007;149(3):261-5.
-
(2007)
Acta Neurochir (Wien)
, vol.149
, Issue.3
, pp. 261-265
-
-
Gallego, J.M.1
Barcia, J.A.2
Barcia-Marino, C.3
-
24
-
-
0028400602
-
In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy
-
Wu MP, et al. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. J Biomed Mater Res. 1994;28(3):387-95.
-
(1994)
J. Biomed. Mater. Res.
, vol.28
, Issue.3
, pp. 387-395
-
-
Wu, M.P.1
-
25
-
-
38949131870
-
Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme
-
Darakchiev BJ, et al., Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme. J Neurosurg. 2008;108(2):236-42.
-
(2008)
J. Neurosurg.
, vol.108
, Issue.2
, pp. 236-242
-
-
Darakchiev, B.J.1
-
26
-
-
20944446096
-
A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme
-
Limentani SA, et al. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme. J Neurooncol. 2005;72(3):241-4.
-
(2005)
J. Neurooncol
, vol.72
, Issue.3
, pp. 241-244
-
-
Limentani, S.A.1
-
27
-
-
33846943352
-
Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylgua-nine in adults with recurrent malignant glioma: New approaches to brain tumor therapy CNS consortium trial
-
Weingart J, et al. Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylgua-nine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. J Clin Oncol. 2007;25(4):399-404.
-
(2007)
J. Clin. Oncol.
, vol.25
, Issue.4
, pp. 399-404
-
-
Weingart, J.1
-
28
-
-
33947191055
-
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
-
Vredenburgh JJ, et al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res. 2007;13(4):1253-9.
-
(2007)
Clin. Cancer Res.
, vol.13
, Issue.4
, pp. 1253-1259
-
-
Vredenburgh, J.J.1
|